Entrada Therapeutics Announces Pricing of Upsized Initial
BOSTON, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients by...
Source: globenewswire.com
Aulani Capuchin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aulani Capuchin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aulani Capuchin Today - Breaking & Trending Today
Entrada Therapeutics Appoints Dr. Peter Kim to its Board of Directors
Posted on 290 Entrada Therapeutics, a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics, today announced the appointment of Peter S. Kim, Ph.D., to its Board of Directors. “Dr. Kim is a pioneering scientist with over 30 years of experience in both academia and the biopharmaceutical industry,” stated Dipal Doshi, President and CEO of Entrada Therapeutics. “He has been recognized with countless honors, awards and appointments throughout the course ...
Source: financialbuzz.com